Generare
a biotech uncovering the next generation of medicines and high-value molecules hiding in soil bacteria
Paris, Francegenerare.bio ↗
Total raised
€25M
€25,000,000
Funding rounds
2
Investors
11
distinct backers
Active since
2024-10
latest 2026-04
Funding by year
EUR raised per year · 2026 YTDSignals
High confidenceRaise-next likelihood32
base rate 44% for Series A
- ▼ Raised very recently
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood9
base rate 12% (2+ rounds)
- ▼ Young (<3y)
Timing: too soon vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-04-02 | Series A | €20M | Alven,Daphni,Existing investors,Galion.exe,TeamPact Ventures,VIVES Partners | View deal → |
| 2024-10-08 | Seed | €5.0M | Better Angle,Business Angels,Galion.exe,Saras Capital,Synbioven,Teampact.ventures+1 more | View deal → |
Investors
11Similar companies
same sector or country- Automotive Cells Company (ACC)€4.4BFrance · Transportation
- Mistral AI€3.5BFrance · AI
- Philips€2.6BNetherlands · Healthtech
- Verkor€2.4BFrance · Energy
- Isomorphic Labs€2.3BUK · Healthtech
- ContentSquare€1.3BFrance · Software